Facebook

Twitter

The placebo effect is when a person experiences a benefit after taking a placebo, medication, or other treatment with no natural therapeutic effect.
https://cancercelltreatment.com/2022/03/03/placebo-clinical-research/

Clinical cancer advances in research are featured in this year’s 2021 ASCO report reflecting progress in various cancers and across prevention and treatment.

Calendula Officinalis is native to Mediterranean region countries but is now grown as an ornamental plant worldwide.
https://cancercelltreatment.com/2022/03/07/calendula-marigolds-pain-relief/

Nitrosamines in drugs—Nitrosamines NDMA are a class of chemicals found in some foods and beverages.
https://cancercelltreatment.com/2022/05/04/nitrosamines-in-drugs/

The sympathetic nervous system is the part of the autonomic nervous system that controls the body's fight-or-flight response.
https://cancercelltreatment.com/2022/03/28/sympathetic-stimulation/

Load More

Cancer Research - New Cancer Treatments and Clinical Trials

April 20, 2022
Est. Reading: 3 minutes

Cancer Research - Stem Cells

Stem cells are essential for living organisms for many reasons. In the human body, they serve as a repair system for the wear and tear that occurs throughout our lives. When a stem cell divides, it can either remain a stem cell or become a more specialized cell, such as a skin cell, muscle cell, or bone cell.

Stem cells are undifferentiated cells that can differentiate into multiple cell types. In other words, stem cells can give rise to indefinitely more cells of the same kind, making them a renewable resource. There are two main types of stem cells: embryonic stem cells and adult stem cells.

stem cells

Embryonic stem cells come from embryos that are three to five days old. Adult stem cells are found in various tissues throughout the body, including the bone marrow, skin, and brain. Embryonic stem cells can differentiate into any cell in the body. It makes them helpful in treating a wide variety of diseases and injuries.

Adult stem cells, on the other hand, are more limited in the types of cells they can become. However, they have the advantage of being less likely to be rejected by the body's immune system. The use of stem cells is a controversial topic, as there are ethical concerns associated with the destruction of human embryos. However, stem cell research has many potential benefits, such as treating diseases and injuries that are currently incurable.

Immunotherapy

Immunotherapy is a treatment that uses the body's immune system to fight cancerous cells. 

Sometimes, doctors use it in conjunction with other treatments like surgery, radiation therapy, or chemotherapy. There are two main types of immunotherapy: active and passive.

Active immunotherapy stimulates the body's immune system to fight mutated cells. 

The body can achieve this by using substances it produces, such as antibodies, or by utilizing manufactured substances that imitate these natural compounds. On the other hand, passive immunotherapy involves giving the body's immune system pre-made substances that will help it fight mutated cells.

Researchers need to conduct more studies to determine the effectiveness of immunotherapy, as it is a relatively new treatment. However, it holds promise as a potential treatment for various cancers. You can find more information about immunotherapy as a treatment for cancer here.

Clinical Trials

Clinical trials are research studies that test new treatments in humans. These treatments may be drugs, medical devices, or other therapies. The purpose of clinical trials is to find out if a new treatment is safe and effective. Clinical trials are an essential step in the development of new therapies.

Several testing phases must precede the approval of a new treatment for use. In phase I clinical trials, a small group of people are given the treatment to see if it is safe. If deemed safe, the treatment advances to phase II clinical trials, where a more extensive group receives the treatment to assess its effectiveness.

cancer treatments

 

Stem cells, immunotherapy, and antibodies are the new beginning in treatments.

Experts discuss the process and review the future of different treatment forms and the associated costs.
In the final quarter of the Stanford Mini Med School, the program addresses some of the most timely and essential topics in contemporary medicine and biosciences.
Stanford Mini Med School is a series arranged and directed by Stanford's School of Medicine and presented by the Stanford Continuing Studies program. Philip Beachy, Ph.D., and Ron Levy, Ph.D., discuss different approaches to cancer therapy, research, and clinical trials, such as drug, antibody, and stem cell therapies.

Advance Video to Dr. Ron Levy, Ph.D. Discussion on his trial examples

Stanford University:
http://www.stanford.edu

Sharing is caring

Leave a Reply

Copyright © 2024 All Rights Reserved
cross linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram